Professors share €26m windfall as drugs firm they founded four years ago sold for €380m

Prof. Luke O'Neill, Co-founder & Chief Scientific Officer & Dr Matt Cooper, Co-founder & Chief Executive Officer Inflazome

Ellie Donnelly

Professors Luke O'Neill and Matt Cooper will share a windfall of up to €26m following the sale of the healthcare business they co-founded just four years ago.